Novo Nordisk weight loss drugs linked to rare eye condition: study
A box of Ozempic and its contents on a table in Dudley, North Tyneside, UK, October 31, 2023. George Frey | Reuters Investors at Novo Nordisk appeared unfazed Thursday by a critical Harvard report linking weight-loss drugs to a rare eye condition. Semaglutide, found in weight-loss drugs such as Ozempic and Novo Nordisk’s Wegovy, may … Read more